Evidence map›Paper›PMID 42346225›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network.

Marilena Di Napoli, Elisabetta Coppola, Carmine D'Aniello, Sarah Scagliarini, Carlo Buonerba, Andrea Muto, Luigi Formisano, Francesco Sabbatino, Davide Bosso, Sabrina Rossetti and 20 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Marilena Di NapoliDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Elisabetta CoppolaDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Carmine D'AnielloDivision of Medical Oncology, AORN dei Colli-Monaldi Hospital, 80131 Naples, Italy.
Sarah ScagliariniDepartment of Medical Oncology, AORN "A. Cardarelli", 80131 Naples, Italy.ORCID 0000-0001-5814-2296
Carlo BuonerbaOncology Unit, "Andrea Tortora" Hospital, 84016 Pagani, Italy.
Andrea MutoDivision of Medical Oncology, "San Giuseppe Moscati" Hospital, 83100 Avellino, Italy.
Luigi FormisanoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Napoli, Italy.ORCID 0000-0001-7294-8595
Francesco SabbatinoOncology Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", 84131 Salerno, Italy.
Davide BossoOncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Sabrina RossettiDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Lorenzo LobiancoDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.ORCID 0000-0002-4124-2837
Rosa TambaroDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Fabrizio Di CostanzoTranslational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle Upon Tyne NE2 4HH, UK.
Pasquale RescignoTranslational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle Upon Tyne NE2 4HH, UK.
Carmela PisanoDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Sabrina Chiara CecereDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Anna PassarelliDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Jole VentrigliaDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Gabriele CalvaneseDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Maria Rosaria LamiaDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Erica PerriDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Roberto ContieriDepartment of Urology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Dario FranzeseDepartment of Urology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Maria Adelina SimeoniNephrology and Dialysis Unite, Department of Translation Medicine Medical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.ORCID 0000-0001-8203-9416
Caterina Mariarosaria GiorgioDermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, 81100 Naples, Italy.
Florinda FeroceDepartment of Pathology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Salvatore StiloInterventional Radiology Unit, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.ORCID 0009-0006-3295-840X
Giovanni PacificoDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Giuseppina CancielloDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.
Sandro PignataDepartment of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS 'G. Pascale', 80131 Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsAxitinibCarcinoma, Renal CellKidney NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedNeoplasm MetastasisRetrospective StudiesAntibodies, Monoclonal, HumanizedAxitinibpembrolizumabaxitinibimmunotherapymetastatic renal cell carcinomapembrolizumabreal-world datareal-world evidenceTKI

Identifiers

PMID42346225
PMCPMC13298080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.